| 2020 | | A Class I Histone Deacetylase Inhibitor Attenuates Insulin Resistance and Inflammation in Palmitate-Treated C2C12 Myotubes and Muscle of HF/HFr Diet Mice | 강엽, 김혜진, 이관우, 전자영, 최성이 |
| 2020 | | A New Objective Health Numeracy Test for Patients with Type 2 Diabetes: Development and Evaluation of Psychometric Properties | 이관우, 이은현 |
| 2020 | | A New Self-management Scale with a Hierarchical Structure for Patients with Type 2 Diabetes | 이관우, 이은현 |
| 2021 | | Acute glucose shift induces the activation of the nlrp3 inflammasome in thp-1 cells | 강엽, 김대중, 김혜진, 이관우, 한승진 |
| 2023 | | Amphiregulin Induces iNOS and COX-2 Expression through NF- κ B and MAPK Signaling in Hepatic Inflammation | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2021 | | Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κ B, MKK7/JNK, and JAK2/STAT1 Signalling Pathways | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2020 | | CCL20 induced by visfatin in macrophages via the NF-kappaB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진 |
| 2022 | | Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study | 김대중, 김혜진, 이관우, 이나미, 전자영, 한승진 |
| 2020 | | Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes | 이관우 |
| 2022 | | Development and psychometric evaluation of a new brief scale to measure eHealth literacy in people with type 2 diabetes | 김혜진, 이관우, 이은현 |
| 2023 | | Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study | 이관우 |
| 2022 | | Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial | 이관우 |
| 2021 | | Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study | 김혜진, 이관우 |
| 2022 | | Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2019 | | GLP1 improves palmitateinduced insulin resistance in human skeletal muscle via SIRT1 activity | 강엽, 김대중, 김혜진, 이관우, 전자영, 최성이, 한승진 |
| 2022 | | Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
| 2024 | | Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus | 이관우 |
| 2023 | | Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients | 김대중, 김혜진, 박범희, 이관우, 전자영, 한승진 |
| 2022 | | In Vivo Two-Photon Imaging Analysis of Dynamic Degradation of Hepatic Lipid Droplets in MS-275-Treated Mouse Liver | 강엽, 곽종영, 김혜진, 이관우, 전자영, 최성이 |
| 2022 | | Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice | 강엽, 김혜진, 이관우, 이광, 최성이, 한승진 |
| 2019 | | Obesity Fact Sheet in Korea, 2018: Data Focusing on Waist Circumference and Obesity-Related Comorbidities | 이관우 |
| 2020 | | Obesity Fact Sheet in Korea, 2019: Prevalence of Obesity and Abdominal Obesity from 2009 to 2018 and Social Factors | 김대중, 이관우 |
| 2021 | | Pathways linking health literacy to self-management in people with type 2 diabetes | 이관우, 이은현 |
| 2023 | | Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells | 강엽, 김혜진, 이관우, 전자영, 최성이 |
| 2019 | | Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice | 강엽, 김혜진, 이관우, 이수진, 최성이, 한승진 |
| 2021 | | Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model | 강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정 |
| 2019 | | Visfatin Induces Inflammation and Insulin Resistance via the NF-kappaB and STAT3 Signaling Pathways in Hepatocytes | 강엽, 김대중, 김혜진, 이관우, 전자영, 최성이, 한승진 |
